TASTE ALTERATION AND QUALITY OF LIFE OF PATIENTS RECEIVING CHEMOTHERAPY

Anooja Antony; Sheela Pavithran

doi:10.22159/ajpcr.2017.v10i12.21049

Authors

Anooja Antony Department of Medical Surgical Nursing, Amrita College of Nursing, Amrita University, Kochi, India.
Sheela Pavithran Department of Medical Surgical Nursing, Amrita College of Nursing, Amrita University, Kochi, India.

DOI:

https://doi.org/10.22159/ajpcr.2017.v10i12.21049

Keywords:

Chemotherapy, Taste alterations, Quality of life, Chemotherapy-induced taste alteration scale, Side effects of chemotherapy

Abstract

Objective: The study was conducted with the aim to determine the taste alteration (TA) and its relation with quality of life (QOL) of patients receiving chemotherapy.

Methods: The present study was undertaken among 100 patients receiving cancer chemotherapy with the aim of identifying the commonly experienced TA and its relation with QOL of the patients. The patients were selected by convenience sampling from a selected Cancer Institute in Kerala.

Results: The study reported that TA was present in all the patients receiving chemotherapy ranging from mild to severe where 50% had moderate and 9% had severe alteration in taste. There were 19% patients who had poor and 45% who had average QOL. The TAs had a moderately negative correlation with QOL (r=âˆ’0.51) indicating that an increase in TA decreases the QOL.

Conclusion: The study evinces that TA is a common side effect of chemotherapy which often impacts the QOL negatively. Hence, it is essential to understand the types of TA and the specific drug causing it. This will enable the health-care team members to develop treatments for these conditions and educate patients regarding the strategies to be adopted to manage the problem, thereby improving patients' QOL.

Â

Downloads

Download data is not yet available.

Author Biography

Anooja Antony, Department of Medical Surgical Nursing, Amrita College of Nursing, Amrita University, Kochi, India.

Medical Surgical Nursing

Professor

References

World Health Organization. WHO Media Centre; 2015. Available from: http://www.who.int/mediacentre/factsheets/fs297/en. [Last cited on 2015 Feb].

Neelakandan K, Babu P, Nair S. Emerging roles for modulation of microRNA signatures in cancer chemoprevention. Curr Cancer Drug Targets 2012;12(6):716-40.

Comeau TB, Epstein JB, Migas C. Taste and smell dysfunction in patients receiving chemotherapy: A review of current knowledge. Support Care Cancer 2001;9(8):575-80.

Drisya PM, James E. Recent updates in the management of chemotherapy induced nausea and vomiting. Asian J Pharm Clin Res 2013;6:5-10.

Osborn HT, Akoh CC. Effects of natural antioxidants on iron catalysed lipid oxidation of structured lipid base emulsions. J Am Oil Chem Soc 2003;80:847-52.

Baltimore, MD. Society for Neurosciences. Available from http://www.brainfacts.org/sensing-thinkig-behaving/learning-and-memory/articles/2012/different-facets-of-memory.

Bernhardson BM, Tishelman C, Rutqvist LE. Chemosensory changes experienced by patients undergoing cancer chemotherapy: A qualitative interview study. J Pain Symptom Manage 2007;34(4):403-12.

Newell S, Sanson-Fisher RW, Girgis A, Bonaventura A. How well do medical oncologistsâ€™ perceptions reflect their patientsâ€™ reported physical and psychosocial problems? Data from a survey of five oncologists. Cancer 1998;83(8):1640-51.

Strasser F, Demmer R, BÃ¶hme C, Schmitz SF, Thuerlimann B, Cerny T, et al. Prevention of docetaxel-or paclitaxel-associated taste alterations in cancer patients with oral glutamine: A randomized, placebo-controlled, double-blind study. Oncologist 2008;13(3):337-46.

Kano T, Kanda K. Development and validation of a chemotherapy-induced taste alteration scale. Oncol Nurs Forum 2013;40(2):E79-85.

Rogers SN, Lowe D. Screening for dysfunction to promote multidisciplinary intervention by using the University of Washington Quality of Life Questionnaire. Arch Otolaryngol Head Neck Surg 2009;135(4):369-75.

Zabernigg A, Gamper EM, Giesinger JM, Rumpold G, Kemmler G, Gattringer K, et al. Taste alterations in cancer patients receiving chemotherapy: A neglected side effect? Oncologist 2010;15(8):913-20.

Hutton JL, Baracos VE, Wismer WV. Chemosensory dysfunction is a primary factor in the evolution of declining nutritional status and quality of life in patients with advanced cancer. J Pain Symptom Manage 2007;33(2):156-65.

Bernhardson BM, Tishelman C, Rutqvist LE. Self-reported taste and smell changes during cancer chemotherapy. Support Care Cancer 2008;16(3):275-83.

Indumathi P, Shanmuga PE. Incidence and management of treatment-related side effects for patients receiving platinum therapy in an outpatient oncology clinic. Asian J Pharm Clin Res 2017;10:117-20.

Trivedi NP, Swaminathan DK, Thankappan K, Chatni S, Kuriakose MA, Iyer S. Comparison of quality of life in advanced laryngeal cancer patients after concurrent chemoradiotherapy versus total laryngectomy. Otolaryngol Head Neck Surg 2008;139:702-7.

Kirthi C, Afzal A, Reddy M, Ali SA, Yerramilli A, Sharma S. A study on the adverse effects of anticancer drugs in an oncology center of a tertiary care hospital. Int J Pharm Pharm Sci 2014;6(2):580-3.

Noviyani R, Indrayathi PA, Budiana IN, Suwiyoga K, Tunas K. Assessment of life quality in patients with Stage IIB-IIIB squamous cell cervical cancer receiving paclitaxel cisplatin chemotherapy regimen by EORTC QLQ-C30 questionnaire in sanglah Hospital Denpasar. Int J Pharm Pharm Sci 2017;9:222-6.